Position in AMRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$33,146,830
+$11,939,922 QoQ
Shares Held
1,914,895
+12.2% QoQ
Ownership
0.600%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 5%
None 0%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $2,153,058,366 across 55 Drug Manufacturers - Specialty & Generic names. AMRX ranks #15 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,542,234 | $398,264,931 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,956,873 | $269,578,854 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
430,844 | $233,444,201 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,259,717 | $212,312,700 | |
| 5 | VTRS |
Viatris Inc
|
10,038,691 | $159,414,410 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
4,256,056 | $104,741,534 | |
| 7 | ALKS |
Alkermes plc.
|
1,831,619 | $95,976,834 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
818,394 | $90,792,627 |
All Filings in AMRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,146,830 | 1,914,895 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $21,206,908 | 1,706,107 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $19,483,970 | 1,546,347 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $16,299,001 | 1,628,272 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $13,030,359 | 1,610,675 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $14,318,293 | 1,708,627 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $14,076,079 | 1,777,283 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $13,483,257 | 1,620,584 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $7,955,608 | 1,252,852 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $7,679,133 | 1,267,184 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $8,016,253 | 1,320,635 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,092,539 | 1,206,763 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,688,465 | 1,189,828 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,434,318 | 1,031,885 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,043,960 | 1,027,117 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,105,947 | 1,042,549 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,340,232 | 1,050,388 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,277,564 | 1,025,795 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,249,201 | 1,095,867 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $6,126,270 | 1,147,242 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,128,534 | 1,196,980 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,582,807 | 1,275,306 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $6,381,825 | 1,396,461 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $5,625,257 | 1,449,809 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $7,241,671 | 1,521,360 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $5,409,333 | 1,554,407 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||